Fresenius | FRE - Ordinary Share Capital



Fresenius reported EUR563.24M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Akzo Nobel EUR 171.01M 86.01M Jun/2025
Alcon AG USD 20M 0 Mar/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
BASF EUR 892.52M 249.48M Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Beiersdorf EUR 220.21M 27.79M Jun/2025
DaVita Healthcare Partners USD 74.22M 74.13M Jun/2025
Demant DKK 205.72M 161.72M Jun/2025
E.ON EUR 2.61B 27.92M Jun/2025
Essilor EUR 456.71M 374.71M Jun/2025
Fresenius EUR 563.24M 237K Jun/2025
Fresenius Medical Care EUR 293.41M 0 Jun/2025
Getinge SEK 136M 0 Dec/2024
Givaudan CHF 92M 0 Jun/2024
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GN Store Nord DKK 145.61M 458.39M Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Novartis USD 793M 0 Dec/2024
Philips EUR 950.57M 762.57M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
RWE EUR 726.08M 1B Jun/2025
Sanofi 1.22B 36.5M Jun/2025
Smith & Nephew USD 875.96M 700.96M Jun/2025